RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition PONE-D-17-28641

The outlook for patients with advanced renal cell cancer (RCC) has been improved by targeted agents including inhibitors of the PI3 kinase (PI3K)-AKT-mTOR axis, although treatment resistance is a major problem. Here, we aimed to understand how RCC cells acquire resistance to PI3K-mTOR inhibition. W...

Celý popis

Podrobná bibliografie
Hlavní autoři: Earwa, P, Anderson, C, Willenbrock, F, Harris, A, Protheroe, A, Macaulay, V
Médium: Journal article
Vydáno: Public Library of Science 2018